| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Autophagy is a therapeutic target in anticancer drug resistance
|
Chen, Suning
|
|
2010
|
1806 |
2 |
p. 220-229
10 p.
|
article
|
| 2 |
Cellular and soluble markers of tumor angiogenesis: From patient selection to the identification of the most appropriate postresistance therapy
|
Bertolini, Francesco
|
|
2010
|
1806 |
2 |
p. 131-137
7 p.
|
article
|
| 3 |
Cisplatin resistance: Preclinical findings and clinical implications
|
Köberle, Beate
|
|
2010
|
1806 |
2 |
p. 172-182
11 p.
|
article
|
| 4 |
Crosstalk and DC-SCRIPT: Expanding nuclear receptor modulation
|
Ansems, M.
|
|
2010
|
1806 |
2 |
p. 193-199
7 p.
|
article
|
| 5 |
Dissecting the transcriptional functions of human DNA topoisomerase I by selective inhibitors: Implications for physiological and therapeutic modulation of enzyme activity
|
Capranico, Giovanni
|
|
2010
|
1806 |
2 |
p. 240-250
11 p.
|
article
|
| 6 |
Editorial Board
|
|
|
2010
|
1806 |
2 |
p. i-
1 p.
|
article
|
| 7 |
Implications of cancer-associated systemic inflammation for biomarker studies
|
Kowalewska, Magdalena
|
|
2010
|
1806 |
2 |
p. 163-171
9 p.
|
article
|
| 8 |
Protein kinase D as a potential new target for cancer therapy
|
LaValle, Courtney R.
|
|
2010
|
1806 |
2 |
p. 183-192
10 p.
|
article
|
| 9 |
Reversible phosphorylation in haematological malignancies: Potential role for protein tyrosine phosphatases in treatment?
|
Ruela-de-Sousa, Roberta R.
|
|
2010
|
1806 |
2 |
p. 287-303
17 p.
|
article
|
| 10 |
Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma
|
Lee, Nikki P.
|
|
2010
|
1806 |
2 |
p. 138-145
8 p.
|
article
|
| 11 |
Serum microRNAs as powerful cancer biomarkers
|
Wittmann, Jürgen
|
|
2010
|
1806 |
2 |
p. 200-207
8 p.
|
article
|
| 12 |
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
|
Wang, Zhiwei
|
|
2010
|
1806 |
2 |
p. 258-267
10 p.
|
article
|
| 13 |
TBX2 and TBX3: The special value for anticancer drug targets
|
Lu, Juan
|
|
2010
|
1806 |
2 |
p. 268-274
7 p.
|
article
|
| 14 |
The Aurora-A/TPX2 complex: A novel oncogenic holoenzyme?
|
Asteriti, Italia Anna
|
|
2010
|
1806 |
2 |
p. 230-239
10 p.
|
article
|
| 15 |
The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas
|
Mahtouk, Karène
|
|
2010
|
1806 |
2 |
p. 208-219
12 p.
|
article
|
| 16 |
The stem cell code in oral epithelial tumorigenesis: ‘The cancer stem cell shift hypothesis’
|
Richard, Vinitha
|
|
2010
|
1806 |
2 |
p. 146-162
17 p.
|
article
|
| 17 |
The translational regulator eIF3a: The tricky eIF3 subunit!
|
Saletta, Federica
|
|
2010
|
1806 |
2 |
p. 275-286
12 p.
|
article
|
| 18 |
Validating cancer drug targets through chemical genetics
|
Burkard, Mark E.
|
|
2010
|
1806 |
2 |
p. 251-257
7 p.
|
article
|
Journal description